T9908
Pembrolizumab
TargetMol
DESCRIPTION
Pembrolizumab is a humanized monoclonal antibody inhibiting the PD-1 receptor and the first in the class of agents called the HER2 dimerization inhibitors that impairs the ability of HER2 to bind to other members of the HER family.
DETAILS
- Cas: 1374853-91-4
- Purity: 99.70%
- Category: Compound
- Molecular Weight: 149 kDa
Lead Time: 4 - 5 weeks
Sign in to view pricingEquivalent Items
| ... Loading